Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Businessweek Archives

A Drugmaker Is Back From Disgrace


In Business This Week: Headliner

A DRUGMAKER IS BACK FROM DISGRACE

Four years after some of its former top officers pleaded guilty to bribing Food & Drug Administration officials, a remade Pharmaceutical Resources is now in the clear. The generic drugmaker, once known as Par Pharmaceutical, on Oct. 26 announced that the agency will review its applications for new products after refusing to do so for four years. CEO Kenneth Sawyer, a former Philadelphia assistant district attorney who took over in 1989, has purged some 37 managers. Now, he aims to win approvals for 25 pending generic-drug applications and reintroduce some older products to rebuild the company's line to more than 100 drugs again.EDITED BY KEITH H. HAMMONDS


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus